Attached files
| file | filename |
|---|---|
| EX-23.2 - EXHIBIT 23.2 - NantHealth, Inc. | exhibit23212312016.htm |
| EX-32.2 - EXHIBIT 32.2 - NantHealth, Inc. | exhibit32212312016.htm |
| EX-32.1 - EXHIBIT 32.1 - NantHealth, Inc. | exhibit32112312016.htm |
| EX-31.2 - EXHIBIT 31.2 - NantHealth, Inc. | exhibit31212312016.htm |
| EX-31.1 - EXHIBIT 31.1 - NantHealth, Inc. | exhibit31112312016.htm |
| EX-21.1 - EXHIBIT 21.1 - NantHealth, Inc. | exhibit21112312016.htm |
| 10-K - 10-K - NantHealth, Inc. | a12312016q4.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-211886) pertaining to the 2016 Equity Incentive Plan and Phantom Unit Plan of NantHealth, Inc. of our report dated March 31, 2017, with respect to the consolidated financial statements of NantHealth, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2016.
/s/ Ernst & Young LLP | |
Los Angeles, California | |
March 31, 2017 | |